Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $495.46 | 13 | 97.9% |
| Education | $10.46 | 1 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABIOMED | $280.13 | 4 | $0 (2023) |
| GlaxoSmithKline, LLC. | $103.10 | 4 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $61.94 | 3 | $0 (2022) |
| Allergan Inc. | $40.36 | 2 | $0 (2018) |
| Olympus America Inc. | $20.39 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $84.33 | 3 | GlaxoSmithKline, LLC. ($84.33) |
| 2023 | $143.76 | 2 | ABIOMED ($124.99) |
| 2022 | $61.94 | 3 | E.R. Squibb & Sons, L.L.C. ($61.94) |
| 2021 | $155.14 | 3 | ABIOMED ($155.14) |
| 2018 | $60.75 | 3 | Allergan Inc. ($40.36) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/08/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $25.29 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $30.91 | General |
| Category: IMMUNOLOGY | ||||||
| 01/11/2024 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: IMMUNOLOGY | ||||||
| 08/24/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: IMMUNOLOGY | ||||||
| 05/30/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/27/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $26.11 | General |
| Category: Cardiovascular | ||||||
| 10/20/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.83 | General |
| Category: Cardiovascular | ||||||
| 03/18/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.00 | General |
| Category: Cardiovascular | ||||||
| 11/16/2021 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2021 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2021 | ABIOMED | Impella (Device) | Education | In-kind items and services | $10.46 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/10/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/16/2018 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/19/2018 | Olympus America Inc. | EVIS EXERA (Device) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Surgical Endoscopy Products | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 120 | 245 | $188,953 | $37,952 |
| 2022 | 3 | 141 | 282 | $206,944 | $43,047 |
| 2021 | 4 | 168 | 368 | $263,341 | $57,870 |
| 2020 | 4 | 244 | 439 | $290,106 | $72,874 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 88 | 206 | $178,396 | $34,755 | 19.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 18 | 21 | $6,615 | $2,036 | 30.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 14 | 18 | $3,942 | $1,161 | 29.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 93 | 212 | $183,592 | $37,208 | 20.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 31 | 49 | $15,435 | $4,068 | 26.4% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 17 | 21 | $7,917 | $1,771 | 22.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 102 | 288 | $233,458 | $50,619 | 21.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 37 | 51 | $15,525 | $4,195 | 27.0% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2021 | 17 | 17 | $10,200 | $1,970 | 19.3% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 12 | 12 | $4,158 | $1,085 | 26.1% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 181 | 371 | $264,424 | $66,250 | 25.1% |
| 31500 | Emergent insertion of breathing tube into windpipe cartilage using an endoscope | Facility | 2020 | 21 | 21 | $12,190 | $2,468 | 20.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 25 | 28 | $7,488 | $2,415 | 32.3% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2020 | 17 | 19 | $6,004 | $1,741 | 29.0% |
About Dr. Paul Goebel, M.D
Dr. Paul Goebel, M.D is a Critical Care Medicine healthcare provider based in Fresno, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851398150.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Goebel, M.D has received a total of $505.92 in payments from pharmaceutical and medical device companies, with $84.33 received in 2024. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($495.46).
As a Medicare-enrolled provider, Goebel has provided services to 673 Medicare beneficiaries, totaling 1,334 services with total Medicare billing of $211,743. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Location Fresno, CA
- Active Since 06/30/2005
- Last Updated 12/02/2010
- Taxonomy Code 207RC0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1851398150
Products in Payments
- Impella (Device) $280.13
- BENLYSTA (Biological) $103.10
- CAMZYOS (Drug) $47.94
- AVYCAZ (Drug) $40.36
- EVIS EXERA (Device) $20.39
- ELIQUIS (Drug) $14.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Fresno
Dr. Vijai Daniel, M.d, Mph, M.D, MPH
Critical Care Medicine — Payments: $439,189
Dr. Lovrdu Pyreddy, M.d, M.D
Critical Care Medicine — Payments: $13,735
Mr. Kuldeep Gill, M.d, M.D
Critical Care Medicine — Payments: $13,598
Dr. Pankaj Mehta, Md, MD
Critical Care Medicine — Payments: $13,109
Dr. Madhava Narala, M.d, M.D
Critical Care Medicine — Payments: $1,070
Rachel Donaldson, Md, Ms, MD, MS
Critical Care Medicine — Payments: $623.84